A new study being published in the journal Pharmacological Reports has found that the marijuana compound cannabidiol (CBD) is effective against brainstem and limbic seizures.
“Cannabidiol (CBD) has been of rapidly growing interest in the epilepsy research field due to its antiseizure properties in preclinical models and patients with pharmacoresistant epilepsy”, states the study, which was published online ahead of print by the National Library of Medicine. “However, little is known about CBD effects in genetic models of epilepsies.”
Here researchers “assessed CBD dose-response effects in the Genetically Epilepsy Prone Rats (GEPR-3) strain, which exhibits two types of epileptic seizures, brainstem-dependent generalized tonic-clonic seizures and limbic seizures.”
